According to a report in Medscape Medical News, this year’s annual American Academy of Allergy, Asthma and Immunology Meeting (AAAAI) will feature promising results from tree nut and wheat desensitization studies.
“The studies are small but they are very encouraging,” said Mary Beth Fasano, MD, from the University of Iowa, who is chair of the program committee.
Until recently, most oral immunotherapy studies were directed toward desensitization to peanuts, according to Fasano. After promising results, the approach is being applied to the desensitization of other allergens, and the data for those studies are just starting to be published.
Two presentations will be made at the AAAAI meeting taking place March 3-6 in Atlanta: A long-term trial of walnut OIT by researchers from the University of Arkansas at Little Rock, and a trial to desensitize patients to wheat using high-gluten wheat flour by researchers from Mount Sinai Health System in New York City.
We’ll report on the findings as they are announced.
Can oral immunotherapy be used for wheat FPIES?